Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Noam Harpaz
Icahn School of Medicine at Mount Sinai, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Celgene
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Noam Harpaz (a Collaborator in this study) receives financial compensation as a consultant for Abbvie and Celgene (companies that manufacture medicines used for the treatment of colorectal cancer).
Molecular pathogenesis of intestinal serrated polyps
Colon cancer is the third most common cancer and the third leading cause of cancer-related mortality in the United States. A proportion of colorectal cancer develops within a subset of lesions called serrated lesions. We have generated genetically modified mice that develop such lesions and showed that the complex communities of non-pathogenic commensal bacteria play a role in the development of intestinal lesions. The study of this novel cancer model may contribute to a better understanding of the mechanisms leading to the formation of serrated lesions and to the development of new strategies for its prevention and treatment.
Filed on September 22, 2016.
Tell us what you know about Noam Harpaz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Noam Harpaz”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Noam Harpaz | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Abbvie | $40,000 - $59,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.